How much funding has Correlia Biosystems raised?

Correlia Biosystems has raised $7.0M in total funding, most recently a Series A round.

Who are Correlia Biosystems's investors?

Correlia Biosystems's investors include NeoTribe Ventures, Y Combinator Continuity Fund, Cota Capital, Regents of the University of California.

Where is Correlia Biosystems headquartered?

Correlia Biosystems is headquartered in Berkeley, California, United States.

What industry is Correlia Biosystems in?

Correlia Biosystems operates in Biotech, Hardware, Healthcare, Lab-on-a-chip.

How many employees does Correlia Biosystems have?

Correlia Biosystems has 11-50 employees.

Correlia Biosystems

Closed

Next-gen blood testing to provide 1000x more data to pharma companies

Berkeley, United States · $7.0M raised

Biotech

Hardware

Healthcare

Lab-on-a-chip

YC W18

Headquarters: Berkeley, California
Employees: 11–50
Website: correliabio.com

Total Funding: $7.0M
Last Round: $7.0M Series ADec 2020
Rounds: 2

About

Correlia Biosystems is a UC Berkeley spinoff company based in Berkeley, CA. Correlia develops innovative microscale tools that accelerate rapid quantification of biomolecules. Our versatile "SimpleScan" technology opens up new biological questions from one microliter of sample, with rapid results that allow for dynamic monitoring of protein expression profiles (rather than simple end-point measurement). Applications range from enabling next-gen proteomic data sets to point-of-care diagnostics.

Summary

Correlia Biosystems is a Biotech company based in Berkeley, United States. It has raised $7.0M in total across 2 rounds, most recently a $7.0M Series A round in Dec 2020. Investors include NeoTribe Ventures, Y Combinator Continuity Fund and Cota Capital.